Clinical Trials Browser

Adenocarcinoma

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

Breast Cancer Metastatic

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasm Female

Breast Neoplasms

Breast Neoplasms

Esophageal Squamous Cell Carcinoma

Breast Neoplasms

HER2-positive Breast Cancer

Brain Neoplasms, Breast Neoplasms

Carcinoma, Transitional Cell

HER2-positive

HER2-positive Gastric Cancer

Colorectal Neoplasms

Intestinal Neoplasms, Colorectal Neoplasms

HER2-positive Breast Cancer

Estrogen Receptor-positive Breast Cancer

Advanced Breast Cancer

Colorectal Neoplasms

Digestive System Neoplasms

Brain Neoplasms

HER2+ Early or Locally Advanced Breast Cancer

Stomach Neoplasms

Breast Neoplasms

Relapsed Pediatric Solid Tumor

Breast Neoplasms

Breast Neoplasms

HER2-positive Breast Cancer

Esophageal Squamous Cell Carcinoma, Biliary Tract Neoplasms, Colorectal Neoplasms

Breast Diseases, Breast Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Neoplasm Metastasis

Gallbladder Neoplasms

Breast Neoplasms

Breast Neoplasms

Stomach Neoplasms

Breast Neoplasms

Stomach Neoplasms

Pathologic Complete Response, Breast Neoplasms

Pancreatic Neoplasms

Breast Neoplasms

Breast Neoplasms

Clinical Trials

A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC

TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

B2023-153

ROME

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

HIST-RIC

VinCaT

FB-12

NeoPATH

Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer

Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower)

Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer

HERES

A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer

Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038

Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China

A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

Efficacy and Safety of Precision Therapy in Refractory Tumor

Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer

HERMET

NeoTPPF

Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib

A Clinical Study of Pyrotinib in Patients With HER2-positive Advanced Colorectal Cancer

Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors

TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)

Pyramid

B-DOCT

Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

SOBER

Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer

KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast Cancer

Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System

Pyrotinib

HERACLES

NEOADAPT

HERZUMA-GC

Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

HERAKLES

Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer

A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs

T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer